All type of patients: 23 trials - 1276.1 (bitherapy MET) - EASE-2 - 1275.9 - EMPA-REG OUTCOME - Barnett - Araki - Rosenstock (1245.49) - Ridderstrale - 1245.29 - 99050 - 1275.19 - DeFronzo - Lewin - Ferrannini - Kadowaki - EMPA-REG PIO (Kovacs) - EMPA-REG MONO (Roden) vs placebo - Rosenstock - Rosenstock DOUBLON ??? - Kadowaki - Ross - Kadowaki - EMPA-REG MET (Haring)
| empagliflozin vs | No demonstrated result | |
| empagliflozin vs add-on linagliptin + MET | No demonstrated result | |
| empagliflozin vs Glimepiride + MET | No demonstrated result | |
| empagliflozin vs linagliptin (add-on MET) | No demonstrated result | |
| empagliflozin vs linagliptin (monotherapy) | No demonstrated result | |
| empagliflozin vs placebo | No demonstrated result | |
| empagliflozin vs placebo (add on MET+/-PIO) | No demonstrated result | |
| empagliflozin vs placebo (add on MET+/-SU) | No demonstrated result | |
| empagliflozin vs Placebo (add-on INS) | No demonstrated result | |
| empagliflozin vs placebo (add-on INS+/-MET) | No demonstrated result | |
| empagliflozin vs placebo (add-on MET) | No demonstrated result | |
| empagliflozin vs placebo (add-on standard treatment) | No demonstrated result | |
| empagliflozin vs placebo add-on linagliptin | No demonstrated result | |
| empagliflozin + MET vs MET | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
